ViiV/GSK NNRTI "761" Development Placed on Hold by FDA

From Positively Aware

February 16, 2011

A promising non-nuke (NNRTI) in development by ViiV, GSK761 (formerly IDX899) was placed on clinical hold by the FDA due to four reports of seizure as part of the Phase 2b trial in treatment experienced patients. Two letters have been sent to study investigators informing them of the events, and including guidance on how to contact patients in order to change their medication from 761 to another suitable alternative and for follow up care.

While this does not mean that development of the drug has been permanently halted, it remains to be seen what the future holds for this drug which, in earlier studies, had shown an improved resistance profile compared to some of the current NNRTIs.

MSF Letter Criticizes Johnson & Johnson for Not Joining Medicines Patent Pool

Peering in the Pipeline

This article was provided by Positively Aware. Visit Positively Aware's website to find out more about the publication.

More on NNRTIs in Development

Coverage of AIDS 2014: The 20th International AIDS Conference

No Longer Cured: HIV Relapse in "Mississippi Child" Raises New Questions

2 Australian Men "Cleared" of HIV After Bone Marrow Transplants

Who Is Most at Risk for Prosecution Under HIV Criminalization Laws?

World Without AIDS: Update on HIV Cure and Vaccine Research

More >>

TheBody.com App

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.